Does LOSARTAN Cause Nephrolithiasis? 67 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 67 reports of Nephrolithiasis have been filed in association with LOSARTAN (Losartan Potassium). This represents 0.3% of all adverse event reports for LOSARTAN.
67
Reports of Nephrolithiasis with LOSARTAN
0.3%
of all LOSARTAN reports
1
Deaths
47
Hospitalizations
How Dangerous Is Nephrolithiasis From LOSARTAN?
Of the 67 reports, 1 (1.5%) resulted in death, 47 (70.1%) required hospitalization, and 10 (14.9%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOSARTAN. However, 67 reports have been filed with the FAERS database.
What Other Side Effects Does LOSARTAN Cause?
Drug ineffective (1,640)
Dizziness (1,553)
Headache (1,256)
Dyspnoea (1,185)
Malaise (1,149)
Hypotension (1,139)
Fatigue (1,116)
Acute kidney injury (1,100)
Cough (1,073)
Blood pressure increased (950)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which LOSARTAN Alternatives Have Lower Nephrolithiasis Risk?
LOSARTAN vs LOSARTAN\LOSARTAN
LOSARTAN vs LOTEPREDNOL ETABONATE
LOSARTAN vs LOTEPREDNOL ETABONATE\TOBRAMYCIN
LOSARTAN vs LOTILANER
LOSARTAN vs LOVASTATIN